AURO-ABACAVIR/LAMIVUDINE
Identification of Auro-Abacavir/Lamivudine
No description |
Google image searchProduct monograph
Active ingredients
abacavir (abacavir sulfate), 600 MG
lamivudine, 300 MG
DIN: 02454513
Dosage form(s): TABLET
Route(s) of administration: ORAL
Schedule: Prescription
Company: AURO PHARMA INC
Date: 31-AUG-2016
ATC:
- J05 — ANTIVIRALS FOR SYSTEMIC USE (ATC, ATC/DDD, )
- J05A — DIRECT ACTING ANTIVIRALS (ATC, ATC/DDD)
- J05AR — Antivirals for treatment of HIV infections, combinations (ATC, ATC/DDD)
- J05AR02 — LAMIVUDINE AND ABACAVIR (ATC/DDD)
Reference brand drug: Kivexa
Pharmaceutical standard: MFR
External Links for Auro-Abacavir/Lamivudine
Search on Google
- Auro-Abacavir/Lamivudine side effects
- Auro-Abacavir/Lamivudine dosage
- abacavir side effects
- abacavir dosage
- lamivudine side effects
- lamivudine dosage
Auro Pharma Inc
Go to Auro Pharma website to see drug product details. Sometimes you can find auro-abacavir/lamivudine photos and/or monograph. If you are a healthcare professional, you may need to enter your license number.